Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Searching for borrelial T cell epitopes associated with antibiotic-refractory Lyme arthritis.

Drouin EE, Glickstein L, Kwok WW, Nepom GT, Steere AC.

Mol Immunol. 2008 Apr;45(8):2323-32. doi: 10.1016/j.molimm.2007.11.010. Epub 2008 Jan 11. Erratum in: Mol Immunol. 2008 Jul;45(12):3508.

4.

Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis.

Steere AC, Angelis SM.

Arthritis Rheum. 2006 Oct;54(10):3079-86. Review. No abstract available.

5.

Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide.

Steere AC, Klitz W, Drouin EE, Falk BA, Kwok WW, Nepom GT, Baxter-Lowe LA.

J Exp Med. 2006 Apr 17;203(4):961-71. Epub 2006 Apr 3.

6.

Lyme disease: uphill struggle.

Abbott A.

Nature. 2006 Feb 2;439(7076):524-5. No abstract available.

PMID:
16452949
7.

Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis.

Gorman JD, David-Vaudey E, Pai M, Lum RF, Criswell LA.

Arthritis Rheum. 2004 Nov;50(11):3476-84.

8.

Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.

Varricchio F, Iskander J, Destefano F, Ball R, Pless R, Braun MM, Chen RT.

Pediatr Infect Dis J. 2004 Apr;23(4):287-94. Review.

PMID:
15071280
9.

An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope.

Willett TA, Meyer AL, Brown EL, Huber BT.

Proc Natl Acad Sci U S A. 2004 Feb 3;101(5):1303-8. Epub 2004 Jan 23.

10.

Poor sales trigger vaccine withdrawal.

Hitt E.

Nat Med. 2002 Apr;8(4):311-2. No abstract available.

PMID:
11927918
11.

Adverse event reports following vaccination for Lyme disease: December 1998-July 2000.

Lathrop SL, Ball R, Haber P, Mootrey GT, Braun MM, Shadomy SV, Ellenberg SS, Chen RT, Hayes EB.

Vaccine. 2002 Feb 22;20(11-12):1603-8.

PMID:
11858868
12.

Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry?

Benoist C, Mathis D.

Nat Immunol. 2001 Sep;2(9):797-801. Review.

PMID:
11526389
13.
14.

HLA, aging, and longevity: a critical reappraisal.

Caruso C, Candore G, Colonna Romano G, Lio D, Bonafè M, Valensin S, Franceschi C.

Hum Immunol. 2000 Sep;61(9):942-9. Review.

PMID:
11053639
15.

Direct enumeration of Borrelia-reactive CD4 T cells ex vivo by using MHC class II tetramers.

Meyer AL, Trollmo C, Crawford F, Marrack P, Steere AC, Huber BT, Kappler J, Hafler DA.

Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11433-8.

16.
17.
18.

Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis.

Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Huber BT.

Science. 1998 Jul 31;281(5377):703-6.

19.

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group.

Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, Nowakowski J, Schmid CH, Laukamp S, Buscarino C, Krause DS.

N Engl J Med. 1998 Jul 23;339(4):209-15.

20.

A role for T cells in the pathogenesis of treatment-resistant Lyme arthritis.

Kamradt T, Krause A, Burmester GR.

Mol Med. 1995 Jul;1(5):486-90. Review. No abstract available.

Supplemental Content

Support Center